These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34144077)
21. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia]. Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161 [TBL] [Abstract][Full Text] [Related]
22. Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study. Naravane AV; Mundae R; Zhou Y; Santilli C; van Kuijk FJGM; Nazari H; Yamanuha J; Emerson GG; Koozekanani DD; Montezuma SR PLoS One; 2021; 16(2):e0247161. PubMed ID: 33596257 [TBL] [Abstract][Full Text] [Related]
23. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis. Zhou S; Gao J; Xu X Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277 [TBL] [Abstract][Full Text] [Related]
24. Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center. Carnevali A; Giannaccare G; Gatti V; Scuteri G; Randazzo G; Scorcia V Eur J Ophthalmol; 2021 Jan; 31(1):10-12. PubMed ID: 32967465 [TBL] [Abstract][Full Text] [Related]
25. Quantifying metamorphopsia in patients with diabetic macular oedema and other macular abnormalities. Achiron A; Lagstein O; Glick M; Gur Z; Bartov E; Burgansky-Eliash Z Acta Ophthalmol; 2015 Dec; 93(8):e649-53. PubMed ID: 25899144 [TBL] [Abstract][Full Text] [Related]
26. Update on the Use of Anti-VEGF Intravitreal Therapies for Retinal Vein Occlusions. Jiang Y; Mieler WF Asia Pac J Ophthalmol (Phila); 2017; 6(6):546-553. PubMed ID: 29204993 [TBL] [Abstract][Full Text] [Related]
28. VEGF inhibitors for AMD and diabetic macular edema. Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545 [No Abstract] [Full Text] [Related]
29. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Nariani A; Williams B; Hariprasad SM Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011 [TBL] [Abstract][Full Text] [Related]
30. IMPACT OF CORONAVIRUS DISEASE PANDEMIC ON INTRAVITREAL INJECTIONS TREATMENT FOR MACULAR DISEASES: Report From a Referral Hospital in Milan. Viola F; Milella P; Pozzo Giuffrida F; Ganci S; Invernizzi A Retina; 2021 Apr; 41(4):701-705. PubMed ID: 32796445 [TBL] [Abstract][Full Text] [Related]
31. Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study. Cho H; Choi KS; Lee JY; Lee D; Choi NK; Lee Y; Bae S BMJ Open; 2019 Sep; 9(9):e030930. PubMed ID: 31542758 [TBL] [Abstract][Full Text] [Related]